Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Renal Cell 11Sarcoma 6Neoplasms 6Lymphoma, Mantle-Cell 6Prostatic Neoplasms 5Lymphoma, Non-Hodgkin 5Rhabdomyosarcoma 4Neoplasm Metastasis 4Kidney Neoplasms 4Gliosarcoma 4Glioblastoma 4Breast Neoplasms 4Brain Neoplasms 4Waldenstrom Macroglobulinemia 3Osteosarcoma 3Melanoma 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Endometrial Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Liposarcoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Glioma 2Fallopian Tube Neoplasms 2Carcinoma, Hepatocellular 2

Interventions

Cytarabine 9Etoposide 4Daunorubicin 4Idarubicin 3Mitoxantrone 2Gemtuzumab 2Clofarabine 2Asparaginase 2tipifarnib 1temsirolimus 1palmitoyl-L-asparaginase 1midostaurin 1etoposide phosphate 1eltrombopag 1dexamethasone acetate 1alvocidib 1aldesleukin 1Whole-Body Irradiation 1Thioguanine 1Proto-Oncogene Proteins c-kit 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1Lenalidomide 1Imatinib Mesylate 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Busulfan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Eosinophilic, Acute × temsirolimus × Clear all
NCT00775593 2017-11-09

AML1107

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡